Marie L. A. Schuttelaar

Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study

Mette Deleuran, Diamant Thaçi, Lisa A. Beck et al. · Journal of the American Academy of Dermatology · 2019 · 248 citations · Full text

Guidelines for diagnosis, prevention, and treatment of hand eczema

Jacob P. Thyssen, Marie L. A. Schuttelaar, José Hernán Alfonso et al. · Contact Dermatitis · 2021 · 228 citations · Full text

Towards global consensus on outcome measures for atopic eczema research: results of the <scp>HOME II</scp> meeting

Jochen Schmitt, Phyllis I. Spuls, Maarten Boers et al. · Allergy · 2012 · 187 citations · Full text

Proactive disease management with 0·03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study

Diamant Thaçi, Sakari Reitamo, María Antonia González Enseñat et al. · British Journal of Dermatology · 2008 · 179 citations · Full text

The European baseline series in 10 European Countries, 2005/2006 – Results of the European Surveillance System on Contact Allergies (ESSCA)

Wolfgang Uter, C. Rämsch, Werner Aberer et al. · Contact Dermatitis · 2009 · 179 citations · Full text